UB Paderborn / Katalog / Suche / in CDI

Antiplatelet and Antiproliferative Effects of SCH 51866, a Novel Type 1 and Type 5 Phosphodiesterase Inhibitor

Journal of cardiovascular pharmacology, 1996-12, Vol.28 (6), p.862-869

1996

Volltextzugriff (PDF)

Inhibition of endothelial derived relaxing factor (EDRF) aggravates ischemic acute renal failure in anesthetized rats

Naunyn-Schmiedeberg's archives of pharmacology, 1993-09, Vol.348 (3), p.305-310

1993

Volltextzugriff (PDF)

Modulation of Circulating Endothelin Levels in Hypertension and Endotoxemia in Rats

Journal of cardiovascular pharmacology, 1991-12, Vol.18 (6), p.895-903

1991

Volltextzugriff (PDF)

Phosphoramidon does not inhibit endogenous endothelin-1 release stimulated by hemorrhage, cytokines and hypoxia in rats

European journal of pharmacology, 1994-05, Vol.257 (1), p.95-102

1994

Volltextzugriff (PDF)

Sildenafil relaxes rabbit clitoral corpus cavernosum

Life sciences (1973), 2000-05, Vol.67 (1), p.23-29

2000

Volltextzugriff (PDF)

Attenuation of ischemic acute renal failure by phosphoramidon in rats

Pharmacology, 1993, Vol.47 (3), p.188

1993

Volltextzugriff (PDF)

Disparate effects of phosphoramidon on blood pressure in SHR and DOCA-salt hypertensive rats

Life sciences (1973), 1993, Vol.53 (10), p.783-793

1993

Volltextzugriff (PDF)

Optimization of purine based PDE1/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male ED

Bioorganic & medicinal chemistry letters, 2005-05, Vol.15 (9), p.2365-2369

2005

Volltextzugriff (PDF)

SAR development of polycyclic guanine derivatives targeted to the discovery of a selective PDE5 inhibitor for treatment of erectile dysfunction

Bioorganic & medicinal chemistry letters, 2004-03, Vol.14 (5), p.1291-1294

2004

Volltextzugriff (PDF)

Phentolamine mesylate relaxes rabbit corpus cavernosum by a nonadrenergic, noncholinergic mechanism

Fundamental & clinical pharmacology, 2001-02, Vol.15 (1), p.1-7

2001

Volltextzugriff (PDF)

Design and synthesis of xanthine analogues as potent and selective PDE5 inhibitors

Bioorganic & medicinal chemistry letters, 2002-11, Vol.12 (21), p.3149-3152

2002

Volltextzugriff (PDF)

Neutral metalloendopeptidase inhibitors as ANF potentiators: sites and mechanisms of action

Canadian journal of physiology and pharmacology, 1991-10, Vol.69 (10), p.1628

1991

Volltextzugriff (PDF)

Augmentation of leukotriene C4 and D4 release due to severe stenosis in the canine coronary artery stimulated by the calcium ionophore A23187

Biochemical pharmacology, 1986-10, Vol.35 (20), p.3593-3599

1986

Volltextzugriff (PDF)

The responses of atrial natriuretic factor concentrations to acute volume changes in conscious rats

Life sciences (1973), 1987-11, Vol.41 (21), p.2339-2347

1987

Volltextzugriff (PDF)

Comparative Vascular and Renal Excretory Effects of Atrial Natriuretic Factor, Sodium Nitroprusside and 8-BR-cGMP in Spontaneously Hypertensive Rats

Clinical and experimental hypertension (1993), 1991, Vol.A13 (5), p.907-915

1991

Volltextzugriff (PDF)

Atrial Natriuretic Factor-Potentiating and Antihypertensive Activity of SCH 34826: An Orally Active Neutral Metalloendopeptidase Inhibitor

Hypertension (Dallas, Tex. 1979), 1990-02, Vol.15 (2), p.152-161

1990

Volltextzugriff (PDF)

Neutral metalloendopeptidase inhibition : a novel means of circulatory modulation

Journal of hypertension, 1990-12, Vol.8 (7), p.S161-S167

1990

Volltextzugriff (PDF)

Inhibition of platelet adhesion and aggregation by E4021, a type V phosphodiesterase inhibitor, in guinea pigs

Naunyn-Schmiedeberg's archives of pharmacology, 1997-04, Vol.355 (4), p.463-469

1997

Volltextzugriff (PDF)

PERIPHERAL CARDIOVASCULAR EFFECTS OF GAMMA AMINOBUTYRIC ACID

VEMULAPALLI, SUBBARAO

1980

Volltextzugriff (PDF)

In vivo inhibition of platelet adhesion by a cGMP-mediated mechanism in balloon catheter injured rat carotid artery

Pharmacology, 1996-04, Vol.52 (4), p.235

1996

Volltextzugriff (PDF)

22. Atrial natriuretic factor-potentiating and antihypertensive activity of N-[2(S)-(acetylthiomethyl)-3-(2-methylphenyl)-L-oxopropyll-L-methionine ethyl ester, an orally active neutral endopeptidase inhibitor

Journal of hypertension, 1991-12, Vol.9 (6), p.S430

1991

Volltextzugriff (PDF)

The blood pressure and renal responses to SCH 34826, a neutral metalloendopeptidase inhibitor, and C-ANF (4–23) in DOCA-salt hypertensive rats

Life sciences (1973), 1991, Vol.49 (5), p.383-391

1991

Volltextzugriff (PDF)

Prolonged neutral endopeptidase inhibition in heart failure

European journal of pharmacology, 1991-05, Vol.198 (1), p.23-30

1991

Volltextzugriff (PDF)

22. Atrial natriuretic factor-potentiating and antihypertensive activity of N-[2(S)-(acetylthiomethyl)-3-(2-methylphenyl)-L-oxopropyll-L-methionine ethyl ester, an orally active neutral endopeptidase inhibitor

Journal of hypertension, 1991, Vol.9, p.S430

1991

Volltextzugriff (PDF)

Cardiovascular and Renal Action of Platelet-Activating Factor in Anesthetized Dogs

Hypertension (Dallas, Tex. 1979), 1984-07, Vol.6 (4), p.489-493

1984

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Antiplatelet and Antiproliferative Effects of SCH 51866, a Novel Type 1 and Type 5 Phosphodiesterase Inhibitor

Inhibition of endothelial derived relaxing factor (EDRF) aggravates ischemic acute renal failure in anesthetized rats

Modulation of Circulating Endothelin Levels in Hypertension and Endotoxemia in Rats

Phosphoramidon does not inhibit endogenous endothelin-1 release stimulated by hemorrhage, cytokines and hypoxia in rats

Sildenafil relaxes rabbit clitoral corpus cavernosum

Attenuation of ischemic acute renal failure by phosphoramidon in rats

Disparate effects of phosphoramidon on blood pressure in SHR and DOCA-salt hypertensive rats

Optimization of purine based PDE1/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male ED

SAR development of polycyclic guanine derivatives targeted to the discovery of a selective PDE5 inhibitor for treatment of erectile dysfunction

Phentolamine mesylate relaxes rabbit corpus cavernosum by a nonadrenergic, noncholinergic mechanism

Design and synthesis of xanthine analogues as potent and selective PDE5 inhibitors

Neutral metalloendopeptidase inhibitors as ANF potentiators: sites and mechanisms of action

Augmentation of leukotriene C4 and D4 release due to severe stenosis in the canine coronary artery stimulated by the calcium ionophore A23187

The responses of atrial natriuretic factor concentrations to acute volume changes in conscious rats

Comparative Vascular and Renal Excretory Effects of Atrial Natriuretic Factor, Sodium Nitroprusside and 8-BR-cGMP in Spontaneously Hypertensive Rats

Atrial Natriuretic Factor-Potentiating and Antihypertensive Activity of SCH 34826: An Orally Active Neutral Metalloendopeptidase Inhibitor

Neutral metalloendopeptidase inhibition : a novel means of circulatory modulation

Inhibition of platelet adhesion and aggregation by E4021, a type V phosphodiesterase inhibitor, in guinea pigs

PERIPHERAL CARDIOVASCULAR EFFECTS OF GAMMA AMINOBUTYRIC ACID

In vivo inhibition of platelet adhesion by a cGMP-mediated mechanism in balloon catheter injured rat carotid artery

22. Atrial natriuretic factor-potentiating and antihypertensive activity of N-[2(S)-(acetylthiomethyl)-3-(2-methylphenyl)-L-oxopropyll-L-methionine ethyl ester, an orally active neutral endopeptidase inhibitor

The blood pressure and renal responses to SCH 34826, a neutral metalloendopeptidase inhibitor, and C-ANF (4–23) in DOCA-salt hypertensive rats

Prolonged neutral endopeptidase inhibition in heart failure

22. Atrial natriuretic factor-potentiating and antihypertensive activity of N-[2(S)-(acetylthiomethyl)-3-(2-methylphenyl)-L-oxopropyll-L-methionine ethyl ester, an orally active neutral endopeptidase inhibitor

Cardiovascular and Renal Action of Platelet-Activating Factor in Anesthetized Dogs

Suchergebnisse filtern